Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey A Meyerhardt, M.D.

Co-Author

This page shows the publications co-authored by Jeffrey Meyerhardt and Andrew Chan.
Connection Strength

6.830
  1. Aspirin Use and Risk of Colorectal Cancer Among Older Adults. JAMA Oncol. 2021 03 01; 7(3):428-435.
    View in: PubMed
    Score: 0.231
  2. Physical activity compared to adiposity and risk of liver-related mortality: Results from two prospective, nationwide cohorts. J Hepatol. 2020 06; 72(6):1062-1069.
    View in: PubMed
    Score: 0.214
  3. Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance). Int J Cancer. 2019 07 15; 145(2):380-389.
    View in: PubMed
    Score: 0.200
  4. Low-Carbohydrate Diet Score and Macronutrient Intake in Relation to Survival After Colorectal Cancer Diagnosis. JNCI Cancer Spectr. 2018 Nov; 2(4):pky077.
    View in: PubMed
    Score: 0.200
  5. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma. JAMA Oncol. 2018 12 01; 4(12):1683-1690.
    View in: PubMed
    Score: 0.198
  6. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies. Hepatology. 2018 05; 67(5):1797-1806.
    View in: PubMed
    Score: 0.188
  7. Fiber Intake and Survival After Colorectal Cancer Diagnosis. JAMA Oncol. 2018 Jan 01; 4(1):71-79.
    View in: PubMed
    Score: 0.185
  8. Marine ?-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis. Gut. 2017 10; 66(10):1790-1796.
    View in: PubMed
    Score: 0.168
  9. Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer. Cancer Prev Res (Phila). 2015 Dec; 8(12):1138-45.
    View in: PubMed
    Score: 0.158
  10. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality. Gastroenterology. 2015 Sep; 149(3):614-22.
    View in: PubMed
    Score: 0.155
  11. Physical activity and male colorectal cancer survival. Arch Intern Med. 2009 Dec 14; 169(22):2102-8.
    View in: PubMed
    Score: 0.106
  12. Interaction of molecular markers and physical activity on mortality in patients with colon cancer. Clin Cancer Res. 2009 Sep 15; 15(18):5931-6.
    View in: PubMed
    Score: 0.104
  13. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology. 2008 Jan; 134(1):21-8.
    View in: PubMed
    Score: 0.091
  14. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006 Aug 01; 24(22):3527-34.
    View in: PubMed
    Score: 0.084
  15. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA. 2005 Aug 24; 294(8):914-23.
    View in: PubMed
    Score: 0.079
  16. Plasma metabolomic profiles for colorectal cancer precursors in women. Eur J Epidemiol. 2022 Jan 15.
    View in: PubMed
    Score: 0.061
  17. Pre-diagnostic telomere length and colorectal cancer risk. Cancer Epidemiol. 2022 Apr; 77:102100.
    View in: PubMed
    Score: 0.061
  18. Long-Term Statin Use, Total Cholesterol Level, and Risk of Colorectal Cancer: A Prospective Cohort Study. Am J Gastroenterol. 2022 01 01; 117(1):158-166.
    View in: PubMed
    Score: 0.061
  19. Spatial Organization and Prognostic Significance of NK and NKT-like Cells via Multimarker Analysis of the Colorectal Cancer Microenvironment. Cancer Immunol Res. 2022 Feb; 10(2):215-227.
    View in: PubMed
    Score: 0.061
  20. Unrestrained eating behavior and risk of digestive system cancers: a prospective cohort study. Am J Clin Nutr. 2021 11 08; 114(5):1612-1624.
    View in: PubMed
    Score: 0.061
  21. Unrestrained eating behavior and risk of mortality: A prospective cohort study. Clin Nutr. 2021 11; 40(11):5419-5429.
    View in: PubMed
    Score: 0.060
  22. Immune cell profiles in the tumor microenvironment of early-onset, intermediate-onset, and later-onset colorectal cancer. Cancer Immunol Immunother. 2022 Apr; 71(4):933-942.
    View in: PubMed
    Score: 0.060
  23. Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma. Oncoimmunology. 2021; 10(1):1956173.
    View in: PubMed
    Score: 0.059
  24. Sugar-sweetened beverage, artificially sweetened beverage and sugar intake and colorectal cancer survival. Br J Cancer. 2021 09; 125(7):1016-1024.
    View in: PubMed
    Score: 0.059
  25. Timing of Aspirin Use in Colorectal Cancer Chemoprevention: A Prospective Cohort Study. J Natl Cancer Inst. 2021 07 01; 113(7):841-851.
    View in: PubMed
    Score: 0.059
  26. Association of bowel movement frequency and laxative use with risk of hepatocellular carcinoma in US women and men. Int J Cancer. 2021 10 15; 149(8):1529-1535.
    View in: PubMed
    Score: 0.059
  27. Postdiagnostic dairy products intake and colorectal cancer survival in US males and females. Am J Clin Nutr. 2021 06 01; 113(6):1636-1646.
    View in: PubMed
    Score: 0.059
  28. Sugar-sweetened beverage intake in adulthood and adolescence and risk of early-onset colorectal cancer among women. Gut. 2021 12; 70(12):2330-2336.
    View in: PubMed
    Score: 0.058
  29. Tumor Long Interspersed Nucleotide Element-1 (LINE-1) Hypomethylation in Relation to Age of Colorectal Cancer Diagnosis and Prognosis. Cancers (Basel). 2021 Apr 22; 13(9).
    View in: PubMed
    Score: 0.058
  30. Prognostic significance of myeloid immune cells and their spatial distribution in the colorectal cancer microenvironment. J Immunother Cancer. 2021 04; 9(4).
    View in: PubMed
    Score: 0.058
  31. Simple Sugar and Sugar-Sweetened Beverage Intake During Adolescence and Risk of Colorectal Cancer Precursors. Gastroenterology. 2021 07; 161(1):128-142.e20.
    View in: PubMed
    Score: 0.058
  32. Association of Fusobacterium nucleatum with Specific T-cell Subsets in the Colorectal Carcinoma Microenvironment. Clin Cancer Res. 2021 05 15; 27(10):2816-2826.
    View in: PubMed
    Score: 0.058
  33. Preexisting Type 2 Diabetes and Survival among Patients with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):757-764.
    View in: PubMed
    Score: 0.057
  34. Association of Inflammatory and Insulinemic Potential of Diet and Lifestyle with Risk of Hepatocellular Carcinoma. Cancer Epidemiol Biomarkers Prev. 2021 04; 30(4):789-796.
    View in: PubMed
    Score: 0.057
  35. Dairy intake during adolescence and risk of colorectal adenoma later in life. Br J Cancer. 2021 03; 124(6):1160-1168.
    View in: PubMed
    Score: 0.057
  36. Plant-Based and Animal-Based Low-Carbohydrate Diets and Risk of Hepatocellular Carcinoma Among US Men and Women. Hepatology. 2021 01; 73(1):175-185.
    View in: PubMed
    Score: 0.057
  37. Dietary intake of branched-chain amino acids and survival after colorectal cancer diagnosis. Int J Cancer. 2020 Dec 19.
    View in: PubMed
    Score: 0.057
  38. Risk Factors and Incidence of Colorectal Cancer According to Major Molecular Subtypes. JNCI Cancer Spectr. 2021 02; 5(1).
    View in: PubMed
    Score: 0.056
  39. The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment. Cancer Immunol Res. 2021 01; 9(1):8-19.
    View in: PubMed
    Score: 0.056
  40. Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2323-2331.
    View in: PubMed
    Score: 0.056
  41. Tumour budding, poorly differentiated clusters, and T-cell response in colorectal cancer. EBioMedicine. 2020 Jul; 57:102860.
    View in: PubMed
    Score: 0.055
  42. Prognostic Significance of Immune Cell Populations Identified by Machine Learning in Colorectal Cancer Using Routine Hematoxylin and Eosin-Stained Sections. Clin Cancer Res. 2020 08 15; 26(16):4326-4338.
    View in: PubMed
    Score: 0.055
  43. Smoking Status at Diagnosis and Colorectal Cancer Prognosis According to Tumor Lymphocytic Reaction. JNCI Cancer Spectr. 2020 Aug; 4(5):pkaa040.
    View in: PubMed
    Score: 0.055
  44. Physical Activity and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Cancer Prev Res (Phila). 2020 08; 13(8):707-714.
    View in: PubMed
    Score: 0.054
  45. Metabolic Profiling of Formalin-Fixed Paraffin-Embedded Tissues Discriminates Normal Colon from Colorectal Cancer. Mol Cancer Res. 2020 06; 18(6):883-890.
    View in: PubMed
    Score: 0.054
  46. An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer. Br J Cancer. 2020 04; 122(9):1367-1377.
    View in: PubMed
    Score: 0.054
  47. No Association Between Vitamin D Supplementation and Risk of Colorectal Adenomas or Serrated Polyps in a Randomized Trial. Clin Gastroenterol Hepatol. 2021 01; 19(1):128-135.e6.
    View in: PubMed
    Score: 0.054
  48. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer. J Pathol. 2020 04; 250(4):397-408.
    View in: PubMed
    Score: 0.054
  49. Effect of Supplementation With Marine ?-3 Fatty Acid on Risk of Colorectal Adenomas and Serrated Polyps in the US General Population: A Prespecified Ancillary Study of a Randomized Clinical Trial. JAMA Oncol. 2020 01 01; 6(1):108-115.
    View in: PubMed
    Score: 0.053
  50. Type 2 Diabetes Prevention Diet and Hepatocellular Carcinoma Risk in US Men and Women. Am J Gastroenterol. 2019 12; 114(12):1870-1877.
    View in: PubMed
    Score: 0.053
  51. Dietary Intake of Branched-Chain Amino Acids and Risk of Colorectal Cancer. Cancer Prev Res (Phila). 2020 01; 13(1):65-72.
    View in: PubMed
    Score: 0.053
  52. Night-Shift Work Duration and Risk of Colorectal Cancer According to IRS1 and IRS2 Expression. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):133-140.
    View in: PubMed
    Score: 0.053
  53. A prospective study of dairy product intake and the risk of hepatocellular carcinoma in U.S. men and women. Int J Cancer. 2020 03 01; 146(5):1241-1249.
    View in: PubMed
    Score: 0.051
  54. Association of Intake of Whole Grains and Dietary Fiber With Risk of Hepatocellular Carcinoma in US Adults. JAMA Oncol. 2019 Jun 01; 5(6):879-886.
    View in: PubMed
    Score: 0.051
  55. Physical activity during adolescence and risk of colorectal adenoma later in life: results from the Nurses' Health Study II. Br J Cancer. 2019 07; 121(1):86-94.
    View in: PubMed
    Score: 0.051
  56. A Prospective Study of Nut Consumption and Risk of Primary Hepatocellular Carcinoma in the U.S. Women and Men. Cancer Prev Res (Phila). 2019 06; 12(6):367-374.
    View in: PubMed
    Score: 0.051
  57. Calcium intake and colon cancer risk subtypes by tumor molecular characteristics. Cancer Causes Control. 2019 Jun; 30(6):637-649.
    View in: PubMed
    Score: 0.051
  58. Dietary Patterns and Risk of Hepatocellular Carcinoma Among U.S. Men and Women. Hepatology. 2019 08; 70(2):577-586.
    View in: PubMed
    Score: 0.050
  59. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. Eur J Cancer. 2019 04; 111:82-93.
    View in: PubMed
    Score: 0.050
  60. Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells. Cancer Prev Res (Phila). 2019 05; 12(5):283-294.
    View in: PubMed
    Score: 0.050
  61. Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells. JNCI Cancer Spectr. 2018 Oct; 2(4):pky058.
    View in: PubMed
    Score: 0.050
  62. Smoking and Risk of Colorectal Cancer Sub-Classified by Tumor-Infiltrating T Cells. J Natl Cancer Inst. 2019 01 01; 111(1):42-51.
    View in: PubMed
    Score: 0.050
  63. Calcium Intake and Survival after Colorectal Cancer Diagnosis. Clin Cancer Res. 2019 03 15; 25(6):1980-1988.
    View in: PubMed
    Score: 0.049
  64. The Amount of Bifidobacterium Genus in Colorectal Carcinoma Tissue in Relation to Tumor Characteristics and Clinical Outcome. Am J Pathol. 2018 12; 188(12):2839-2852.
    View in: PubMed
    Score: 0.049
  65. Fusobacterium nucleatum in Colorectal Cancer Relates to Immune Response Differentially by Tumor Microsatellite Instability Status. Cancer Immunol Res. 2018 11; 6(11):1327-1336.
    View in: PubMed
    Score: 0.049
  66. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour. Eur J Cancer. 2018 11; 103:98-107.
    View in: PubMed
    Score: 0.049
  67. TIME (Tumor Immunity in the MicroEnvironment) classification based on tumor CD274 (PD-L1) expression status and tumor-infiltrating lymphocytes in colorectal carcinomas. Oncoimmunology. 2018; 7(7):e1442999.
    View in: PubMed
    Score: 0.047
  68. Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality. Gastroenterology. 2018 03; 154(4):916-926.e9.
    View in: PubMed
    Score: 0.046
  69. Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells. Oncotarget. 2017 Oct 20; 8(50):87379-87389.
    View in: PubMed
    Score: 0.045
  70. Influence of dietary insulin scores on survival in colorectal cancer patients. Br J Cancer. 2017 Sep 26; 117(7):1079-1087.
    View in: PubMed
    Score: 0.045
  71. Calcium intake and risk of colorectal cancer according to expression status of calcium-sensing receptor (CASR). Gut. 2018 08; 67(8):1475-1483.
    View in: PubMed
    Score: 0.045
  72. Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue. JAMA Oncol. 2017 Jul 01; 3(7):921-927.
    View in: PubMed
    Score: 0.045
  73. Body mass index and risk of colorectal carcinoma subtypes classified by tumor differentiation status. Eur J Epidemiol. 2017 05; 32(5):393-407.
    View in: PubMed
    Score: 0.044
  74. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status. J Clin Oncol. 2017 Jun 01; 35(16):1836-1844.
    View in: PubMed
    Score: 0.044
  75. Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers. Int J Cancer. 2017 06 15; 140(12):2648-2656.
    View in: PubMed
    Score: 0.044
  76. Periodontal disease, tooth loss and colorectal cancer risk: Results from the Nurses' Health Study. Int J Cancer. 2017 Feb 01; 140(3):646-652.
    View in: PubMed
    Score: 0.043
  77. Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location. Clin Transl Gastroenterol. 2016 Nov 03; 7(11):e200.
    View in: PubMed
    Score: 0.043
  78. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep. 2016 10 18; 17(4):1206.
    View in: PubMed
    Score: 0.043
  79. MicroRNA let-7, T Cells, and Patient Survival in Colorectal Cancer. Cancer Immunol Res. 2016 11; 4(11):927-935.
    View in: PubMed
    Score: 0.043
  80. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival. Oncotarget. 2016 Aug 23; 7(34):55098-55109.
    View in: PubMed
    Score: 0.042
  81. Relationship of prediagnostic body mass index with survival after colorectal cancer: Stage-specific associations. Int J Cancer. 2016 09 01; 139(5):1065-72.
    View in: PubMed
    Score: 0.041
  82. Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate. Int J Cancer. 2016 08 15; 139(4):854-68.
    View in: PubMed
    Score: 0.041
  83. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma. Cell Rep. 2016 Apr 26; 15(4):857-865.
    View in: PubMed
    Score: 0.041
  84. Soluble tumour necrosis factor receptor type II and survival in colorectal cancer. Br J Cancer. 2016 04 26; 114(9):995-1002.
    View in: PubMed
    Score: 0.041
  85. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival. Clin Cancer Res. 2016 08 01; 22(15):3841-8.
    View in: PubMed
    Score: 0.041
  86. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer. Ann Surg Oncol. 2016 Mar; 23(3):908-17.
    View in: PubMed
    Score: 0.040
  87. Postdiagnostic intake of one-carbon nutrients and alcohol in relation to colorectal cancer survival. Am J Clin Nutr. 2015 Nov; 102(5):1134-41.
    View in: PubMed
    Score: 0.040
  88. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut. 2016 12; 65(12):1973-1980.
    View in: PubMed
    Score: 0.039
  89. Television watching and colorectal cancer survival in men. Cancer Causes Control. 2015 Oct; 26(10):1467-76.
    View in: PubMed
    Score: 0.039
  90. Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. J Natl Cancer Inst. 2015 Jan; 107(1):345.
    View in: PubMed
    Score: 0.037
  91. Tumor LINE-1 methylation level and microsatellite instability in relation to colorectal cancer prognosis. J Natl Cancer Inst. 2014 Sep; 106(9).
    View in: PubMed
    Score: 0.037
  92. SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features. Ann Surg Oncol. 2014 Dec; 21(13):4164-73.
    View in: PubMed
    Score: 0.036
  93. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review. Mol Cancer. 2014 May 31; 13:135.
    View in: PubMed
    Score: 0.036
  94. Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014 Mar; 99(3):587-98.
    View in: PubMed
    Score: 0.035
  95. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1142-52.
    View in: PubMed
    Score: 0.034
  96. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with ß-catenin (CTNNB1) status. Cancer Res. 2013 Mar 01; 73(5):1600-10.
    View in: PubMed
    Score: 0.033
  97. Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol. 2013 Apr; 26(4):465-84.
    View in: PubMed
    Score: 0.033
  98. Prospective study of family history and colorectal cancer risk by tumor LINE-1 methylation level. J Natl Cancer Inst. 2013 Jan 16; 105(2):130-40.
    View in: PubMed
    Score: 0.033
  99. Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. N Engl J Med. 2012 Oct 25; 367(17):1596-606.
    View in: PubMed
    Score: 0.032
  100. Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies. Arch Surg. 2012 Aug; 147(8):715-23.
    View in: PubMed
    Score: 0.032
  101. Body mass index and risk of colorectal cancer according to fatty acid synthase expression in the nurses' health study. J Natl Cancer Inst. 2012 Mar 07; 104(5):415-20.
    View in: PubMed
    Score: 0.031
  102. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J Natl Cancer Inst. 2011 Oct 19; 103(20):1540-51.
    View in: PubMed
    Score: 0.030
  103. Reported behavior of eating anything at anytime and risk of colorectal cancer in women. Int J Cancer. 2012 Mar 15; 130(6):1395-400.
    View in: PubMed
    Score: 0.030
  104. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer. JAMA. 2011 Apr 27; 305(16):1685-94.
    View in: PubMed
    Score: 0.029
  105. Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers. Cancer. 2011 Apr 01; 117(7):1399-408.
    View in: PubMed
    Score: 0.028
  106. Dietary insulin load, dietary insulin index, and colorectal cancer. Cancer Epidemiol Biomarkers Prev. 2010 Dec; 19(12):3020-6.
    View in: PubMed
    Score: 0.028
  107. HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol. 2010 May; 176(5):2292-301.
    View in: PubMed
    Score: 0.027
  108. Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009 Sep 15; 101(6):916-23.
    View in: PubMed
    Score: 0.026
  109. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol. 2009 Jan 10; 27(2):176-85.
    View in: PubMed
    Score: 0.025
  110. Cohort study of fatty acid synthase expression and patient survival in colon cancer. J Clin Oncol. 2008 Dec 10; 26(35):5713-20.
    View in: PubMed
    Score: 0.025
  111. Hormone replacement therapy and survival after colorectal cancer diagnosis. J Clin Oncol. 2006 Dec 20; 24(36):5680-6.
    View in: PubMed
    Score: 0.022
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.